3.7. NR2F1 Was More Highly Expressed in Inflammatory CAFs, and in CAFs with Lymph Node Metastasis and in More Advanced Stages, but No Differences Were Observed in Cancer Cells. This evidence concerns the gene NR2F1 and metastatic malignant neoplasm in the lymph nodes.